Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Positive phase III trials results for citicoline

Feb. 11, 1997

Essential fatty acids in schizophrenia

Feb. 11, 1997

U.S. researchers report significant advance in gene therapy for hearing disorders

Feb. 11, 1997

Takeda prepares NO production inhibitors

Feb. 11, 1997

U.S. and European investigators describe agents for CNS disorders

Feb. 11, 1997

Spiro compounds for CNS disorders disclosed by Takeda

Feb. 11, 1997

BioSpecifics Technologies is issued 9th U.S. patent for use of collagenase enzyme

Feb. 10, 1997

Launch date for Aricept revealed

Feb. 10, 1997

Analgesic/antiinflammatory agent from Merck KGaA

Feb. 10, 1997

Gruenenthal prepares analgesics

Feb. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...